Related Experiment Video
Updated: Oct 3, 2025

09:09
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
8.0K
Ubiquitin and Legionella: From bench to bedside
Ines Tomaskovic1, Alexis Gonzalez1, Ivan Dikic2
1Institute of Biochemistry II, Goethe University School of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Seminars in Cell & Developmental Biology
|February 18, 2022
Summary
Legionella pneumophila causes Legionnaires' disease by hijacking host cell pathways, particularly the ubiquitin system. Understanding these interactions is key to developing new treatments for this atypical pneumonia.
Area of Science:
- Microbiology
- Pathogenesis
- Immunology
Background:
- Legionella pneumophila is a Gram-negative bacterium causing Legionnaires' disease, a severe pneumonia.
- Despite research, Legionnaires' disease remains a public health issue due to Legionella's complex virulence mechanisms.
Purpose of the Study:
- To review current knowledge on Legionella pneumophila from medical, biochemical, and molecular viewpoints.
- To highlight Legionella's exploitation of the host ubiquitin system for replication and dissemination.
- To discuss innovative technologies for improved understanding and treatment of Legionnaires' disease.
Main Methods:
- Literature review synthesizing medical, biochemical, and molecular data.
- Analysis of host-pathogen interactions, focusing on ubiquitin system manipulation.
- Exploration of interdisciplinary approaches and novel technologies.
Main Results:
- Legionella pneumophila employs multiple effector proteins to hijack host cell pathways, including conventional and unconventional ubiquitination.
- The bacterium's virulence relies on subverting the host ubiquitin system for intracellular replication.
- Current understanding encompasses clinical presentation, diagnostics, treatment, and pathogenesis.
Conclusions:
- Legionella pneumophila's ability to manipulate the host ubiquitin system is central to its pathogenicity.
- Further research integrating innovative technologies is crucial for advancing treatment and prevention strategies.
- A comprehensive understanding of Legionella-host interactions offers new therapeutic avenues.

